Global Prostate Cancer Screening Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Prostate Cancer Screening market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Screening is forecast to a readjusted size of US$ 22410 million by 2030 with a CAGR of 7.9% during review period.
The research report highlights the growth potential of the global Prostate Cancer Screening market. Prostate Cancer Screening are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prostate Cancer Screening. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prostate Cancer Screening market.
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
Key Features:
The report on Prostate Cancer Screening market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prostate Cancer Screening market. It may include historical data, market segmentation by Type (e.g., Physical Exam, Laboratory Tests), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prostate Cancer Screening market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prostate Cancer Screening market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prostate Cancer Screening industry. This include advancements in Prostate Cancer Screening technology, Prostate Cancer Screening new entrants, Prostate Cancer Screening new investment, and other innovations that are shaping the future of Prostate Cancer Screening.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prostate Cancer Screening market. It includes factors influencing customer ' purchasing decisions, preferences for Prostate Cancer Screening product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prostate Cancer Screening market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prostate Cancer Screening market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prostate Cancer Screening market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prostate Cancer Screening industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prostate Cancer Screening market.
Market Segmentation:
Prostate Cancer Screening market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Prostate Cancer Screening market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Screening is forecast to a readjusted size of US$ 22410 million by 2030 with a CAGR of 7.9% during review period.
The research report highlights the growth potential of the global Prostate Cancer Screening market. Prostate Cancer Screening are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prostate Cancer Screening. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prostate Cancer Screening market.
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
Key Features:
The report on Prostate Cancer Screening market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prostate Cancer Screening market. It may include historical data, market segmentation by Type (e.g., Physical Exam, Laboratory Tests), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prostate Cancer Screening market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prostate Cancer Screening market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prostate Cancer Screening industry. This include advancements in Prostate Cancer Screening technology, Prostate Cancer Screening new entrants, Prostate Cancer Screening new investment, and other innovations that are shaping the future of Prostate Cancer Screening.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prostate Cancer Screening market. It includes factors influencing customer ' purchasing decisions, preferences for Prostate Cancer Screening product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prostate Cancer Screening market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prostate Cancer Screening market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prostate Cancer Screening market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prostate Cancer Screening industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prostate Cancer Screening market.
Market Segmentation:
Prostate Cancer Screening market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Physical Exam
- Laboratory Tests
- Imaging Tests
- Gleason Score
- TNM Score
- Genetic Tests
- Digital Rectal Exam
- Biopsy
- Hospitals
- Clinics
- Research Labs
- Cancer Institutes
- Diagnostic Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Almac
- Bayer
- Beckman Coulter
- BiomйRieux
- Genomic Health
- Mayo Clinic
- Mdxhealth
- Roche Diagnostics
- Rosetta Genomics
- Thermo Fisher Scientific
- Hologic
- Myriad Genetics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate Cancer Screening Market Size 2019-2030
2.1.2 Prostate Cancer Screening Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prostate Cancer Screening Segment by Type
2.2.1 Physical Exam
2.2.2 Laboratory Tests
2.2.3 Imaging Tests
2.2.4 Gleason Score
2.2.5 TNM Score
2.2.6 Genetic Tests
2.2.7 Digital Rectal Exam
2.2.8 Biopsy
2.3 Prostate Cancer Screening Market Size by Type
2.3.1 Prostate Cancer Screening Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
2.4 Prostate Cancer Screening Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Labs
2.4.4 Cancer Institutes
2.4.5 Diagnostic Centers
2.4.6 Others
2.5 Prostate Cancer Screening Market Size by Application
2.5.1 Prostate Cancer Screening Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
3 PROSTATE CANCER SCREENING MARKET SIZE BY PLAYER
3.1 Prostate Cancer Screening Market Size Market Share by Players
3.1.1 Global Prostate Cancer Screening Revenue by Players (2019-2024)
3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROSTATE CANCER SCREENING BY REGIONS
4.1 Prostate Cancer Screening Market Size by Regions (2019-2024)
4.2 Americas Prostate Cancer Screening Market Size Growth (2019-2024)
4.3 APAC Prostate Cancer Screening Market Size Growth (2019-2024)
4.4 Europe Prostate Cancer Screening Market Size Growth (2019-2024)
4.5 Middle East & Africa Prostate Cancer Screening Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Prostate Cancer Screening Market Size by Country (2019-2024)
5.2 Americas Prostate Cancer Screening Market Size by Type (2019-2024)
5.3 Americas Prostate Cancer Screening Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Screening Market Size by Region (2019-2024)
6.2 APAC Prostate Cancer Screening Market Size by Type (2019-2024)
6.3 APAC Prostate Cancer Screening Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prostate Cancer Screening by Country (2019-2024)
7.2 Europe Prostate Cancer Screening Market Size by Type (2019-2024)
7.3 Europe Prostate Cancer Screening Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate Cancer Screening by Region (2019-2024)
8.2 Middle East & Africa Prostate Cancer Screening Market Size by Type (2019-2024)
8.3 Middle East & Africa Prostate Cancer Screening Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROSTATE CANCER SCREENING MARKET FORECAST
10.1 Global Prostate Cancer Screening Forecast by Regions (2025-2030)
10.1.1 Global Prostate Cancer Screening Forecast by Regions (2025-2030)
10.1.2 Americas Prostate Cancer Screening Forecast
10.1.3 APAC Prostate Cancer Screening Forecast
10.1.4 Europe Prostate Cancer Screening Forecast
10.1.5 Middle East & Africa Prostate Cancer Screening Forecast
10.2 Americas Prostate Cancer Screening Forecast by Country (2025-2030)
10.2.1 United States Prostate Cancer Screening Market Forecast
10.2.2 Canada Prostate Cancer Screening Market Forecast
10.2.3 Mexico Prostate Cancer Screening Market Forecast
10.2.4 Brazil Prostate Cancer Screening Market Forecast
10.3 APAC Prostate Cancer Screening Forecast by Region (2025-2030)
10.3.1 China Prostate Cancer Screening Market Forecast
10.3.2 Japan Prostate Cancer Screening Market Forecast
10.3.3 Korea Prostate Cancer Screening Market Forecast
10.3.4 Southeast Asia Prostate Cancer Screening Market Forecast
10.3.5 India Prostate Cancer Screening Market Forecast
10.3.6 Australia Prostate Cancer Screening Market Forecast
10.4 Europe Prostate Cancer Screening Forecast by Country (2025-2030)
10.4.1 Germany Prostate Cancer Screening Market Forecast
10.4.2 France Prostate Cancer Screening Market Forecast
10.4.3 UK Prostate Cancer Screening Market Forecast
10.4.4 Italy Prostate Cancer Screening Market Forecast
10.4.5 Russia Prostate Cancer Screening Market Forecast
10.5 Middle East & Africa Prostate Cancer Screening Forecast by Region (2025-2030)
10.5.1 Egypt Prostate Cancer Screening Market Forecast
10.5.2 South Africa Prostate Cancer Screening Market Forecast
10.5.3 Israel Prostate Cancer Screening Market Forecast
10.5.4 Turkey Prostate Cancer Screening Market Forecast
10.5.5 GCC Countries Prostate Cancer Screening Market Forecast
10.6 Global Prostate Cancer Screening Forecast by Type (2025-2030)
10.7 Global Prostate Cancer Screening Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Prostate Cancer Screening Product Offered
11.1.3 Abbott Laboratories Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Almac
11.2.1 Almac Company Information
11.2.2 Almac Prostate Cancer Screening Product Offered
11.2.3 Almac Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Almac Main Business Overview
11.2.5 Almac Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Prostate Cancer Screening Product Offered
11.3.3 Bayer Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Information
11.4.2 Beckman Coulter Prostate Cancer Screening Product Offered
11.4.3 Beckman Coulter Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Beckman Coulter Main Business Overview
11.4.5 Beckman Coulter Latest Developments
11.5 BiomйRieux
11.5.1 BiomйRieux Company Information
11.5.2 BiomйRieux Prostate Cancer Screening Product Offered
11.5.3 BiomйRieux Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BiomйRieux Main Business Overview
11.5.5 BiomйRieux Latest Developments
11.6 Genomic Health
11.6.1 Genomic Health Company Information
11.6.2 Genomic Health Prostate Cancer Screening Product Offered
11.6.3 Genomic Health Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Genomic Health Main Business Overview
11.6.5 Genomic Health Latest Developments
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Information
11.7.2 Mayo Clinic Prostate Cancer Screening Product Offered
11.7.3 Mayo Clinic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Mayo Clinic Main Business Overview
11.7.5 Mayo Clinic Latest Developments
11.8 Mdxhealth
11.8.1 Mdxhealth Company Information
11.8.2 Mdxhealth Prostate Cancer Screening Product Offered
11.8.3 Mdxhealth Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Mdxhealth Main Business Overview
11.8.5 Mdxhealth Latest Developments
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Information
11.9.2 Roche Diagnostics Prostate Cancer Screening Product Offered
11.9.3 Roche Diagnostics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Roche Diagnostics Main Business Overview
11.9.5 Roche Diagnostics Latest Developments
11.10 Rosetta Genomics
11.10.1 Rosetta Genomics Company Information
11.10.2 Rosetta Genomics Prostate Cancer Screening Product Offered
11.10.3 Rosetta Genomics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rosetta Genomics Main Business Overview
11.10.5 Rosetta Genomics Latest Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Information
11.11.2 Thermo Fisher Scientific Prostate Cancer Screening Product Offered
11.11.3 Thermo Fisher Scientific Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Thermo Fisher Scientific Main Business Overview
11.11.5 Thermo Fisher Scientific Latest Developments
11.12 Hologic
11.12.1 Hologic Company Information
11.12.2 Hologic Prostate Cancer Screening Product Offered
11.12.3 Hologic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Hologic Main Business Overview
11.12.5 Hologic Latest Developments
11.13 Myriad Genetics
11.13.1 Myriad Genetics Company Information
11.13.2 Myriad Genetics Prostate Cancer Screening Product Offered
11.13.3 Myriad Genetics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Myriad Genetics Main Business Overview
11.13.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate Cancer Screening Market Size 2019-2030
2.1.2 Prostate Cancer Screening Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prostate Cancer Screening Segment by Type
2.2.1 Physical Exam
2.2.2 Laboratory Tests
2.2.3 Imaging Tests
2.2.4 Gleason Score
2.2.5 TNM Score
2.2.6 Genetic Tests
2.2.7 Digital Rectal Exam
2.2.8 Biopsy
2.3 Prostate Cancer Screening Market Size by Type
2.3.1 Prostate Cancer Screening Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
2.4 Prostate Cancer Screening Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Labs
2.4.4 Cancer Institutes
2.4.5 Diagnostic Centers
2.4.6 Others
2.5 Prostate Cancer Screening Market Size by Application
2.5.1 Prostate Cancer Screening Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
3 PROSTATE CANCER SCREENING MARKET SIZE BY PLAYER
3.1 Prostate Cancer Screening Market Size Market Share by Players
3.1.1 Global Prostate Cancer Screening Revenue by Players (2019-2024)
3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROSTATE CANCER SCREENING BY REGIONS
4.1 Prostate Cancer Screening Market Size by Regions (2019-2024)
4.2 Americas Prostate Cancer Screening Market Size Growth (2019-2024)
4.3 APAC Prostate Cancer Screening Market Size Growth (2019-2024)
4.4 Europe Prostate Cancer Screening Market Size Growth (2019-2024)
4.5 Middle East & Africa Prostate Cancer Screening Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Prostate Cancer Screening Market Size by Country (2019-2024)
5.2 Americas Prostate Cancer Screening Market Size by Type (2019-2024)
5.3 Americas Prostate Cancer Screening Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Screening Market Size by Region (2019-2024)
6.2 APAC Prostate Cancer Screening Market Size by Type (2019-2024)
6.3 APAC Prostate Cancer Screening Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prostate Cancer Screening by Country (2019-2024)
7.2 Europe Prostate Cancer Screening Market Size by Type (2019-2024)
7.3 Europe Prostate Cancer Screening Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate Cancer Screening by Region (2019-2024)
8.2 Middle East & Africa Prostate Cancer Screening Market Size by Type (2019-2024)
8.3 Middle East & Africa Prostate Cancer Screening Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROSTATE CANCER SCREENING MARKET FORECAST
10.1 Global Prostate Cancer Screening Forecast by Regions (2025-2030)
10.1.1 Global Prostate Cancer Screening Forecast by Regions (2025-2030)
10.1.2 Americas Prostate Cancer Screening Forecast
10.1.3 APAC Prostate Cancer Screening Forecast
10.1.4 Europe Prostate Cancer Screening Forecast
10.1.5 Middle East & Africa Prostate Cancer Screening Forecast
10.2 Americas Prostate Cancer Screening Forecast by Country (2025-2030)
10.2.1 United States Prostate Cancer Screening Market Forecast
10.2.2 Canada Prostate Cancer Screening Market Forecast
10.2.3 Mexico Prostate Cancer Screening Market Forecast
10.2.4 Brazil Prostate Cancer Screening Market Forecast
10.3 APAC Prostate Cancer Screening Forecast by Region (2025-2030)
10.3.1 China Prostate Cancer Screening Market Forecast
10.3.2 Japan Prostate Cancer Screening Market Forecast
10.3.3 Korea Prostate Cancer Screening Market Forecast
10.3.4 Southeast Asia Prostate Cancer Screening Market Forecast
10.3.5 India Prostate Cancer Screening Market Forecast
10.3.6 Australia Prostate Cancer Screening Market Forecast
10.4 Europe Prostate Cancer Screening Forecast by Country (2025-2030)
10.4.1 Germany Prostate Cancer Screening Market Forecast
10.4.2 France Prostate Cancer Screening Market Forecast
10.4.3 UK Prostate Cancer Screening Market Forecast
10.4.4 Italy Prostate Cancer Screening Market Forecast
10.4.5 Russia Prostate Cancer Screening Market Forecast
10.5 Middle East & Africa Prostate Cancer Screening Forecast by Region (2025-2030)
10.5.1 Egypt Prostate Cancer Screening Market Forecast
10.5.2 South Africa Prostate Cancer Screening Market Forecast
10.5.3 Israel Prostate Cancer Screening Market Forecast
10.5.4 Turkey Prostate Cancer Screening Market Forecast
10.5.5 GCC Countries Prostate Cancer Screening Market Forecast
10.6 Global Prostate Cancer Screening Forecast by Type (2025-2030)
10.7 Global Prostate Cancer Screening Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Prostate Cancer Screening Product Offered
11.1.3 Abbott Laboratories Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Almac
11.2.1 Almac Company Information
11.2.2 Almac Prostate Cancer Screening Product Offered
11.2.3 Almac Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Almac Main Business Overview
11.2.5 Almac Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Prostate Cancer Screening Product Offered
11.3.3 Bayer Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Information
11.4.2 Beckman Coulter Prostate Cancer Screening Product Offered
11.4.3 Beckman Coulter Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Beckman Coulter Main Business Overview
11.4.5 Beckman Coulter Latest Developments
11.5 BiomйRieux
11.5.1 BiomйRieux Company Information
11.5.2 BiomйRieux Prostate Cancer Screening Product Offered
11.5.3 BiomйRieux Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BiomйRieux Main Business Overview
11.5.5 BiomйRieux Latest Developments
11.6 Genomic Health
11.6.1 Genomic Health Company Information
11.6.2 Genomic Health Prostate Cancer Screening Product Offered
11.6.3 Genomic Health Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Genomic Health Main Business Overview
11.6.5 Genomic Health Latest Developments
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Information
11.7.2 Mayo Clinic Prostate Cancer Screening Product Offered
11.7.3 Mayo Clinic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Mayo Clinic Main Business Overview
11.7.5 Mayo Clinic Latest Developments
11.8 Mdxhealth
11.8.1 Mdxhealth Company Information
11.8.2 Mdxhealth Prostate Cancer Screening Product Offered
11.8.3 Mdxhealth Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Mdxhealth Main Business Overview
11.8.5 Mdxhealth Latest Developments
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Information
11.9.2 Roche Diagnostics Prostate Cancer Screening Product Offered
11.9.3 Roche Diagnostics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Roche Diagnostics Main Business Overview
11.9.5 Roche Diagnostics Latest Developments
11.10 Rosetta Genomics
11.10.1 Rosetta Genomics Company Information
11.10.2 Rosetta Genomics Prostate Cancer Screening Product Offered
11.10.3 Rosetta Genomics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rosetta Genomics Main Business Overview
11.10.5 Rosetta Genomics Latest Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Information
11.11.2 Thermo Fisher Scientific Prostate Cancer Screening Product Offered
11.11.3 Thermo Fisher Scientific Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Thermo Fisher Scientific Main Business Overview
11.11.5 Thermo Fisher Scientific Latest Developments
11.12 Hologic
11.12.1 Hologic Company Information
11.12.2 Hologic Prostate Cancer Screening Product Offered
11.12.3 Hologic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Hologic Main Business Overview
11.12.5 Hologic Latest Developments
11.13 Myriad Genetics
11.13.1 Myriad Genetics Company Information
11.13.2 Myriad Genetics Prostate Cancer Screening Product Offered
11.13.3 Myriad Genetics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Myriad Genetics Main Business Overview
11.13.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prostate Cancer Screening Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Physical Exam
Table 3. Major Players of Laboratory Tests
Table 4. Major Players of Imaging Tests
Table 5. Major Players of Gleason Score
Table 6. Major Players of TNM Score
Table 7. Major Players of Genetic Tests
Table 8. Major Players of Digital Rectal Exam
Table 9. Major Players of Biopsy
Table 10. Prostate Cancer Screening Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 12. Global Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 13. Prostate Cancer Screening Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 14. Global Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 15. Global Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 16. Global Prostate Cancer Screening Revenue by Players (2019-2024) & ($ Millions)
Table 17. Global Prostate Cancer Screening Revenue Market Share by Player (2019-2024)
Table 18. Prostate Cancer Screening Key Players Head office and Products Offered
Table 19. Prostate Cancer Screening Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Prostate Cancer Screening Market Size by Regions 2019-2024 & ($ Millions)
Table 23. Global Prostate Cancer Screening Market Size Market Share by Regions (2019-2024)
Table 24. Global Prostate Cancer Screening Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Prostate Cancer Screening Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Prostate Cancer Screening Market Size by Country (2019-2024) & ($ Millions)
Table 27. Americas Prostate Cancer Screening Market Size Market Share by Country (2019-2024)
Table 28. Americas Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 29. Americas Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 30. Americas Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 31. Americas Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 32. APAC Prostate Cancer Screening Market Size by Region (2019-2024) & ($ Millions)
Table 33. APAC Prostate Cancer Screening Market Size Market Share by Region (2019-2024)
Table 34. APAC Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 35. APAC Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 36. APAC Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 37. APAC Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 38. Europe Prostate Cancer Screening Market Size by Country (2019-2024) & ($ Millions)
Table 39. Europe Prostate Cancer Screening Market Size Market Share by Country (2019-2024)
Table 40. Europe Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 41. Europe Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 42. Europe Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 43. Europe Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 44. Middle East & Africa Prostate Cancer Screening Market Size by Region (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Region (2019-2024)
Table 46. Middle East & Africa Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 48. Middle East & Africa Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 50. Key Market Drivers & Growth Opportunities of Prostate Cancer Screening
Table 51. Key Market Challenges & Risks of Prostate Cancer Screening
Table 52. Key Industry Trends of Prostate Cancer Screening
Table 53. Global Prostate Cancer Screening Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 54. Global Prostate Cancer Screening Market Size Market Share Forecast by Regions (2025-2030)
Table 55. Global Prostate Cancer Screening Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 56. Global Prostate Cancer Screening Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 57. Abbott Laboratories Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 58. Abbott Laboratories Prostate Cancer Screening Product Offered
Table 59. Abbott Laboratories Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Abbott Laboratories Main Business
Table 61. Abbott Laboratories Latest Developments
Table 62. Almac Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 63. Almac Prostate Cancer Screening Product Offered
Table 64. Almac Main Business
Table 65. Almac Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Almac Latest Developments
Table 67. Bayer Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 68. Bayer Prostate Cancer Screening Product Offered
Table 69. Bayer Main Business
Table 70. Bayer Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Bayer Latest Developments
Table 72. Beckman Coulter Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 73. Beckman Coulter Prostate Cancer Screening Product Offered
Table 74. Beckman Coulter Main Business
Table 75. Beckman Coulter Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Beckman Coulter Latest Developments
Table 77. BiomйRieux Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 78. BiomйRieux Prostate Cancer Screening Product Offered
Table 79. BiomйRieux Main Business
Table 80. BiomйRieux Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. BiomйRieux Latest Developments
Table 82. Genomic Health Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 83. Genomic Health Prostate Cancer Screening Product Offered
Table 84. Genomic Health Main Business
Table 85. Genomic Health Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Genomic Health Latest Developments
Table 87. Mayo Clinic Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 88. Mayo Clinic Prostate Cancer Screening Product Offered
Table 89. Mayo Clinic Main Business
Table 90. Mayo Clinic Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Mayo Clinic Latest Developments
Table 92. Mdxhealth Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 93. Mdxhealth Prostate Cancer Screening Product Offered
Table 94. Mdxhealth Main Business
Table 95. Mdxhealth Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Mdxhealth Latest Developments
Table 97. Roche Diagnostics Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 98. Roche Diagnostics Prostate Cancer Screening Product Offered
Table 99. Roche Diagnostics Main Business
Table 100. Roche Diagnostics Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Roche Diagnostics Latest Developments
Table 102. Rosetta Genomics Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 103. Rosetta Genomics Prostate Cancer Screening Product Offered
Table 104. Rosetta Genomics Main Business
Table 105. Rosetta Genomics Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Rosetta Genomics Latest Developments
Table 107. Thermo Fisher Scientific Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 108. Thermo Fisher Scientific Prostate Cancer Screening Product Offered
Table 109. Thermo Fisher Scientific Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Thermo Fisher Scientific Main Business
Table 111. Thermo Fisher Scientific Latest Developments
Table 112. Hologic Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 113. Hologic Prostate Cancer Screening Product Offered
Table 114. Hologic Main Business
Table 115. Hologic Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Hologic Latest Developments
Table 117. Myriad Genetics Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 118. Myriad Genetics Prostate Cancer Screening Product Offered
Table 119. Myriad Genetics Main Business
Table 120. Myriad Genetics Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Myriad Genetics Latest Developments
Table 1. Prostate Cancer Screening Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Physical Exam
Table 3. Major Players of Laboratory Tests
Table 4. Major Players of Imaging Tests
Table 5. Major Players of Gleason Score
Table 6. Major Players of TNM Score
Table 7. Major Players of Genetic Tests
Table 8. Major Players of Digital Rectal Exam
Table 9. Major Players of Biopsy
Table 10. Prostate Cancer Screening Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 12. Global Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 13. Prostate Cancer Screening Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 14. Global Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 15. Global Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 16. Global Prostate Cancer Screening Revenue by Players (2019-2024) & ($ Millions)
Table 17. Global Prostate Cancer Screening Revenue Market Share by Player (2019-2024)
Table 18. Prostate Cancer Screening Key Players Head office and Products Offered
Table 19. Prostate Cancer Screening Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Prostate Cancer Screening Market Size by Regions 2019-2024 & ($ Millions)
Table 23. Global Prostate Cancer Screening Market Size Market Share by Regions (2019-2024)
Table 24. Global Prostate Cancer Screening Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Prostate Cancer Screening Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Prostate Cancer Screening Market Size by Country (2019-2024) & ($ Millions)
Table 27. Americas Prostate Cancer Screening Market Size Market Share by Country (2019-2024)
Table 28. Americas Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 29. Americas Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 30. Americas Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 31. Americas Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 32. APAC Prostate Cancer Screening Market Size by Region (2019-2024) & ($ Millions)
Table 33. APAC Prostate Cancer Screening Market Size Market Share by Region (2019-2024)
Table 34. APAC Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 35. APAC Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 36. APAC Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 37. APAC Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 38. Europe Prostate Cancer Screening Market Size by Country (2019-2024) & ($ Millions)
Table 39. Europe Prostate Cancer Screening Market Size Market Share by Country (2019-2024)
Table 40. Europe Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 41. Europe Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 42. Europe Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 43. Europe Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 44. Middle East & Africa Prostate Cancer Screening Market Size by Region (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Region (2019-2024)
Table 46. Middle East & Africa Prostate Cancer Screening Market Size by Type (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Table 48. Middle East & Africa Prostate Cancer Screening Market Size by Application (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Table 50. Key Market Drivers & Growth Opportunities of Prostate Cancer Screening
Table 51. Key Market Challenges & Risks of Prostate Cancer Screening
Table 52. Key Industry Trends of Prostate Cancer Screening
Table 53. Global Prostate Cancer Screening Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 54. Global Prostate Cancer Screening Market Size Market Share Forecast by Regions (2025-2030)
Table 55. Global Prostate Cancer Screening Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 56. Global Prostate Cancer Screening Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 57. Abbott Laboratories Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 58. Abbott Laboratories Prostate Cancer Screening Product Offered
Table 59. Abbott Laboratories Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Abbott Laboratories Main Business
Table 61. Abbott Laboratories Latest Developments
Table 62. Almac Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 63. Almac Prostate Cancer Screening Product Offered
Table 64. Almac Main Business
Table 65. Almac Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Almac Latest Developments
Table 67. Bayer Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 68. Bayer Prostate Cancer Screening Product Offered
Table 69. Bayer Main Business
Table 70. Bayer Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Bayer Latest Developments
Table 72. Beckman Coulter Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 73. Beckman Coulter Prostate Cancer Screening Product Offered
Table 74. Beckman Coulter Main Business
Table 75. Beckman Coulter Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Beckman Coulter Latest Developments
Table 77. BiomйRieux Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 78. BiomйRieux Prostate Cancer Screening Product Offered
Table 79. BiomйRieux Main Business
Table 80. BiomйRieux Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. BiomйRieux Latest Developments
Table 82. Genomic Health Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 83. Genomic Health Prostate Cancer Screening Product Offered
Table 84. Genomic Health Main Business
Table 85. Genomic Health Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Genomic Health Latest Developments
Table 87. Mayo Clinic Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 88. Mayo Clinic Prostate Cancer Screening Product Offered
Table 89. Mayo Clinic Main Business
Table 90. Mayo Clinic Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Mayo Clinic Latest Developments
Table 92. Mdxhealth Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 93. Mdxhealth Prostate Cancer Screening Product Offered
Table 94. Mdxhealth Main Business
Table 95. Mdxhealth Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Mdxhealth Latest Developments
Table 97. Roche Diagnostics Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 98. Roche Diagnostics Prostate Cancer Screening Product Offered
Table 99. Roche Diagnostics Main Business
Table 100. Roche Diagnostics Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Roche Diagnostics Latest Developments
Table 102. Rosetta Genomics Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 103. Rosetta Genomics Prostate Cancer Screening Product Offered
Table 104. Rosetta Genomics Main Business
Table 105. Rosetta Genomics Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Rosetta Genomics Latest Developments
Table 107. Thermo Fisher Scientific Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 108. Thermo Fisher Scientific Prostate Cancer Screening Product Offered
Table 109. Thermo Fisher Scientific Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Thermo Fisher Scientific Main Business
Table 111. Thermo Fisher Scientific Latest Developments
Table 112. Hologic Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 113. Hologic Prostate Cancer Screening Product Offered
Table 114. Hologic Main Business
Table 115. Hologic Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Hologic Latest Developments
Table 117. Myriad Genetics Details, Company Type, Prostate Cancer Screening Area Served and Its Competitors
Table 118. Myriad Genetics Prostate Cancer Screening Product Offered
Table 119. Myriad Genetics Main Business
Table 120. Myriad Genetics Prostate Cancer Screening Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Myriad Genetics Latest Developments
LIST OF FIGURES
Figure 1. Prostate Cancer Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Screening Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Prostate Cancer Screening Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Prostate Cancer Screening Sales Market Share by Country/Region (2023)
Figure 8. Prostate Cancer Screening Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Prostate Cancer Screening Market Size Market Share by Type in 2023
Figure 10. Prostate Cancer Screening in Hospitals
Figure 11. Global Prostate Cancer Screening Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Prostate Cancer Screening in Clinics
Figure 13. Global Prostate Cancer Screening Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Prostate Cancer Screening in Research Labs
Figure 15. Global Prostate Cancer Screening Market: Research Labs (2019-2024) & ($ Millions)
Figure 16. Prostate Cancer Screening in Cancer Institutes
Figure 17. Global Prostate Cancer Screening Market: Cancer Institutes (2019-2024) & ($ Millions)
Figure 18. Prostate Cancer Screening in Diagnostic Centers
Figure 19. Global Prostate Cancer Screening Market: Diagnostic Centers (2019-2024) & ($ Millions)
Figure 20. Prostate Cancer Screening in Others
Figure 21. Global Prostate Cancer Screening Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Prostate Cancer Screening Market Size Market Share by Application in 2023
Figure 23. Global Prostate Cancer Screening Revenue Market Share by Player in 2023
Figure 24. Global Prostate Cancer Screening Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 26. APAC Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 27. Europe Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 29. Americas Prostate Cancer Screening Value Market Share by Country in 2023
Figure 30. United States Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Prostate Cancer Screening Market Size Market Share by Region in 2023
Figure 35. APAC Prostate Cancer Screening Market Size Market Share by Type in 2023
Figure 36. APAC Prostate Cancer Screening Market Size Market Share by Application in 2023
Figure 37. China Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Prostate Cancer Screening Market Size Market Share by Country in 2023
Figure 44. Europe Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Figure 45. Europe Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Figure 46. Germany Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 60. APAC Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 61. Europe Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 63. United States Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 64. Canada Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 67. China Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 68. Japan Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 69. Korea Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 71. India Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 72. Australia Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 73. Germany Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 74. France Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 75. UK Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 76. Italy Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 77. Russia Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 78. Spain Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 81. Israel Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 84. Global Prostate Cancer Screening Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Prostate Cancer Screening Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Prostate Cancer Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Screening Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Prostate Cancer Screening Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Prostate Cancer Screening Sales Market Share by Country/Region (2023)
Figure 8. Prostate Cancer Screening Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Prostate Cancer Screening Market Size Market Share by Type in 2023
Figure 10. Prostate Cancer Screening in Hospitals
Figure 11. Global Prostate Cancer Screening Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Prostate Cancer Screening in Clinics
Figure 13. Global Prostate Cancer Screening Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Prostate Cancer Screening in Research Labs
Figure 15. Global Prostate Cancer Screening Market: Research Labs (2019-2024) & ($ Millions)
Figure 16. Prostate Cancer Screening in Cancer Institutes
Figure 17. Global Prostate Cancer Screening Market: Cancer Institutes (2019-2024) & ($ Millions)
Figure 18. Prostate Cancer Screening in Diagnostic Centers
Figure 19. Global Prostate Cancer Screening Market: Diagnostic Centers (2019-2024) & ($ Millions)
Figure 20. Prostate Cancer Screening in Others
Figure 21. Global Prostate Cancer Screening Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Prostate Cancer Screening Market Size Market Share by Application in 2023
Figure 23. Global Prostate Cancer Screening Revenue Market Share by Player in 2023
Figure 24. Global Prostate Cancer Screening Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 26. APAC Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 27. Europe Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Prostate Cancer Screening Market Size 2019-2024 ($ Millions)
Figure 29. Americas Prostate Cancer Screening Value Market Share by Country in 2023
Figure 30. United States Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Prostate Cancer Screening Market Size Market Share by Region in 2023
Figure 35. APAC Prostate Cancer Screening Market Size Market Share by Type in 2023
Figure 36. APAC Prostate Cancer Screening Market Size Market Share by Application in 2023
Figure 37. China Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Prostate Cancer Screening Market Size Market Share by Country in 2023
Figure 44. Europe Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Figure 45. Europe Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Figure 46. Germany Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Prostate Cancer Screening Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Prostate Cancer Screening Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 60. APAC Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 61. Europe Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 63. United States Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 64. Canada Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 67. China Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 68. Japan Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 69. Korea Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 71. India Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 72. Australia Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 73. Germany Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 74. France Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 75. UK Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 76. Italy Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 77. Russia Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 78. Spain Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 81. Israel Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Prostate Cancer Screening Market Size 2025-2030 ($ Millions)
Figure 84. Global Prostate Cancer Screening Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Prostate Cancer Screening Market Size Market Share Forecast by Application (2025-2030)
